Feasibility of pooled blood screening for anti-HIV, anti-HCV and HBsAg in recent seroconverters: Application of robust regression models

被引：0
|
作者：
Galai, N
Novack, L
Orgel, M
Yaari, A
Shinar, E
Litvak, E
Sarov, B
机构：
[1] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
4
引用
收藏
页码：44S / 45S
页数：2
相关论文
共 50 条
  • [21] Evaluation of LIAISON® XL System for HBsAg, and Anti-HCV and Anti-HIV/Ag p24
    De Paschale, Massimo
    Manco, Maria Teresa
    Belvisi, Luisa
    Cagnin, Debora
    Cerulli, Teresa
    Paganini, Alessia
    Arpino, Olivia
    Cianflone, Annalisa
    Agrappi, Carlo
    Mirri, Paola
    Clerici, Pierangelo
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (03) : 489 - 496
  • [22] The Evaluation of HBsAg, Anti-HCV and Anti-HIV Results in Blood Donors Applying to the Transfusion Center of Batman State Regional Hospital
    Turk-Dagi, Hatice
    KLIMIK JOURNAL, 2011, 24 (03) : 173 - 175
  • [23] The incidence of hbsag, anti-HCV, anti-HIV and treponema pallidum antibodies in repeated blood donors for the eastern part of republic of macedonia
    Kamcev, N. K.
    Vitlarova, V. J.
    Kamceva, K. M.
    Nevenka, N., V
    Kamceva, K. G.
    VOX SANGUINIS, 2008, 95 : 269 - 270
  • [24] HBsAg, Anti-HCV, and Anti-HIV Seroprevalence Among Patients Presenting to a State Hospital between 2014 and 2018
    Bayindir Bilman, Fulya
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2019, 8
  • [25] DISTRIBUTION OF ABO AND RH BLOOD GROUPS AND SEROPREVALENCE OF HBSAG, ANTI-HCV, ANTI-HIV AND SYPHILIS IN HEALTHY DONORS: A SINGLE CENTER EXPERIENCE
    Ekinci, O.
    Kara, O.
    Dogan, A.
    Demircioglu, S.
    Demir, C.
    LEUKEMIA RESEARCH, 2017, 61 : S27 - S27
  • [26] Siirt Devlet Hastanesi'ne Basvuran Hastalarda HBsAg, Anti-HBs, Anti-HCV ve Anti-HIV Seroprevalansi
    Tunc, Nedim
    Eraydin, Hakan
    Cetinkaya, Emin
    Oduncu, Mehmet Kadir
    Toy, Seyhmus
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2011, 17 (01): : 7 - 11
  • [27] COMPARISON OF ANTI-HIV AND ANTI-HCV THERAPY COSTS IN THE CZECH REPUBLIC
    Stefancikova, I
    Mazel, T.
    Haluska, M.
    Chytilova, P.
    Strnadova, M.
    Mahovska, R.
    Vocelka, M.
    VALUE IN HEALTH, 2019, 22 : S649 - S649
  • [28] THE PREVALENCE OF HBSAG AND ANTI-HCV IN BLOOD DONORS OF TIRANA
    Seferi, I
    Abazaj, Z. H.
    Vila, M.
    Metka, A.
    Pengu, J.
    Koraqi, A.
    VOX SANGUINIS, 2012, 103 : 164 - 165
  • [29] Prevalence of HBsAg and anti-HCV in Saudi blood donors
    Altamimi, W
    Altraif, I
    Elsheikh, M
    Alkshan, A
    Qasem, L
    Sohaibani, M
    ANNALS OF SAUDI MEDICINE, 1998, 18 (01) : 60 - 62
  • [30] The incidence of hbsag, anti-HCV, anti-HIV and Treponema Pallidum anti bodies in blood donors who donate blood for the first time from the eastern part of republic of macedonia
    Vitlarova, J.
    Kamcev, N.
    Velickova, N.
    Kamceva, G.
    Dejanova, V
    VOX SANGUINIS, 2008, 95 : 272 - 273
12345